Works in Cancer Chemotherapy & Pharmacology, 2014, Vol 74, Issue 5
Results: 27
A first-in-human study of the anti-α5β1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumors.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Pharmacokinetics of the chimeric anti-GD2 antibody, ch14.18, in children with high-risk neuroblastoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
GEIS 2013 guidelines for gastrointestinal sarcomas (GIST).
- Published in:
- 2014
- By:
- Publication type:
- journal article
A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Mechanistic pharmacokinetic/pharmacodynamic modeling of in vivo tumor uptake, catabolism, and tumor response of trastuzumab maytansinoid conjugates.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 969, doi. 10.1007/s00280-014-2561-2
- By:
- Publication type:
- Article
A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 911, doi. 10.1007/s00280-014-2563-0
- By:
- Publication type:
- Article
Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 899, doi. 10.1007/s00280-014-2564-z
- By:
- Publication type:
- Article
A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 917, doi. 10.1007/s00280-014-2567-9
- By:
- Publication type:
- Article
TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 947, doi. 10.1007/s00280-014-2568-8
- By:
- Publication type:
- Article
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 955, doi. 10.1007/s00280-014-2569-7
- By:
- Publication type:
- Article
Evaluation of gefitinib efficacy according to body surface area in patients with non-small cell lung cancer harboring an EGFR mutation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 939, doi. 10.1007/s00280-014-2570-1
- By:
- Publication type:
- Article
Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 927, doi. 10.1007/s00280-014-2571-0
- By:
- Publication type:
- Article
Non-surgical treatment versus radical esophagectomy for clinical T1N0M0 esophageal carcinoma: a single-center experience.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 995, doi. 10.1007/s00280-014-2573-y
- By:
- Publication type:
- Article
Expression of a novel peptide derived from PCNA damages DNA and reverses cisplatin resistance.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 981, doi. 10.1007/s00280-014-2574-x
- By:
- Publication type:
- Article
Pharmacokinetics of the chimeric anti-G antibody, ch14.18, in children with high-risk neuroblastoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 1047, doi. 10.1007/s00280-014-2575-9
- By:
- Publication type:
- Article
A first-in-human study of the anti-α5β1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 1039, doi. 10.1007/s00280-014-2576-8
- By:
- Publication type:
- Article
Antitumor activity of the selective ALK inhibitor alectinib in models of intracranial metastases.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 1023, doi. 10.1007/s00280-014-2578-6
- By:
- Publication type:
- Article
Phase I trial of hepatic arterial infusion (HAI) of floxuridine with modified oxaliplatin, 5-fluorouracil and leucovorin (m-FOLFOX6) in Chinese patients with unresectable liver metastases from colorectal cancer.
- Published in:
- 2014
- By:
- Publication type:
- Report
Leucovorin rescue allows effective high-dose pralatrexate treatment and an increase in therapeutic index in mesothelioma xenografts.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 1029, doi. 10.1007/s00280-014-2580-z
- By:
- Publication type:
- Article
Prognostic value of human papillomavirus in anal squamous cell carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 1033, doi. 10.1007/s00280-014-2582-x
- By:
- Publication type:
- Article
Clinical study of the novel cyclin-dependent kinase inhibitor dinaciclib in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 1057, doi. 10.1007/s00280-014-2583-9
- By:
- Publication type:
- Article
Heat shock protein 90 (HSP90) is overexpressed in p16-negative oropharyngeal squamous cell carcinoma, and its inhibition in vitro potentiates the effects of chemoradiation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 1015, doi. 10.1007/s00280-014-2584-8
- By:
- Publication type:
- Article
Effectiveness and safety of cabazitaxel plus prednisolone chemotherapy for metastatic castration-resistant prostatic carcinoma: data on Korean patients obtained by the cabazitaxel compassionate-use program.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 1005, doi. 10.1007/s00280-014-2579-5
- By:
- Publication type:
- Article
Significant association of combination of OCT4, NANOG, and SOX2 gene polymorphisms in susceptibility and response to treatment in North Indian breast cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 1065, doi. 10.1007/s00280-014-2588-4
- By:
- Publication type:
- Article
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function.
- Published in:
- 2014
- By:
- Publication type:
- Report
Predicting success in regulatory approval from Phase I results.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 1099, doi. 10.1007/s00280-014-2596-4
- By:
- Publication type:
- Article
GEIS 2013 guidelines for gastrointestinal sarcomas (GIST).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 883, doi. 10.1007/s00280-014-2547-0
- By:
- Publication type:
- Article